Tessera gets up to $50M from the Gates Foundation; Tvardi’s reverse merger
Plus, news about Sensorion, Soleno Therapeutics, Corvus and Hansa Biopharma: Tessera Therapeutics bags up to $50M for sickle cell disease R&D: The investment is part … Sign up to read this article for free. Get free access to a limited …